Improvements in early detection and treatment have led to a growing prevalence of survivors
of cancer worldwide. Models of care fail to address adequately the breadth of physical …

Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other health care providers on integrative approaches to …

Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …

Vulvar cancer is annually diagnosed in an estimated 6,470 individuals and the vast majority
are histologically squamous cell carcinomas. Vulvar cancer accounts for 5% to 8% of …

Chemotherapy is one of the widely used anticancer treatments that involves the use of
powerful cytotoxic drugs to stop tumor growth by targeting rapidly dividing cells through …

When peripheral neuropathy occurs due to chemotherapy treatment, it is referred to as
chemotherapy-induced peripheral neuropathy (CIPN). Typically, symptoms are sensory …

With increasing attention on the essential roles of the tumour microenvironment in recent
years, the nervous system has emerged as a novel and crucial facilitator of cancer growth. In …

Bortezomib, a first-generation proteasome inhibitor widely used in chemotherapy for
hematologic malignancy, has effective anti-cancer activity but often causes severe …

Vincristine (VCR), an alkaloid extracted from vinca, is often used in combination with other
chemotherapeutic drugs to treat a variety of cancers, such as acute lymphoblastic leukaemia …